SCM Pharma expands vial filling capability

Invests more than £500,000 in equipment to be installed in the summer

SCM Pharma’s technical director Neal Wesley says the new equipment will allow SCM Pharma to fill various types of potent materials in different sized vials

Sterile manufacturing specialist SCM Pharma is set to expand its vial filling capability after winning several clinical trials and commercial supply contracts.

The UK-based contract development and manufacturing organisation (CDMO) has invested more than £500,000 in new vial filling equipment that will arrive this summer and command a dedicated suite at its facility.

SCM Pharma undertakes vial filling across many projects and the new automated filler will deliver increased capacity, efficiency and integrate with its containment isolator. The move follows increased demand for liquid and powder filling from new and existing clients with scale-up requirements.

Neal Wesley, technical director at SCM Pharma, said: ‘The new kit will give us a true containment system for vial filling in that it will allow us to fill various types of potent materials in different sized vials while being totally safe for the product and operator.

‘By having a system that isn’t compromised in any way, we are able to handle more cytotoxic products such as oncology drugs, which we can safely fill at speed into vials under aseptic conditions to meet the demands of our clients.’

Although the investment will be a step change in SCM’s current filling capabilities, it remains at a scale that will be of interest mainly to companies requiring products for clinical trials and the supply of licensed drugs needed in niche markets such as orphan drugs.

Companies